Skip to content
Link copied to clipboard

Endo to close Alabama facilities, cut 875 jobs

The company will close its manufacturing and distribution facilities in Huntsville, Ala.

A logo sign outside of a facility occupied by Endo Pharmaceuticals in Malvern, Pennsylvania on May 30, 2015. Photo Credit: Kristoffer Tripplaar/ Sipa USA *** Please Use Credit from Credit Field ***
A logo sign outside of a facility occupied by Endo Pharmaceuticals in Malvern, Pennsylvania on May 30, 2015. Photo Credit: Kristoffer Tripplaar/ Sipa USA *** Please Use Credit from Credit Field ***Read moreAP
    by Linda Loyd
    Published 

Endo International, with U.S. headquarters in Malvern, announced Friday that it will close its manufacturing and distribution facilities in Huntsville, Ala.

About 875 jobs will be lost, including 35 open positions. No jobs or operations will be impacted in Malvern, where 600 work, a company spokeswoman said. Endo will transfer products made in Huntsville, primarily generic medicines including hydrocodone/APAP, oxycodone, oxybutynin, prednisone, and methylprednisolone, to its other manufacturing sites.